Niclosamide market expected to grow rapidly by 2027

Get a sample report Buy the full report Niclosamide market Research is an intelligence report with meticulous efforts undertaken to study accurate and valuable information. The data that was examined takes into account both existing top players and future competitors. The business strategies of major players and new industries entering …

Read More »


Norwood, MA, May 19, 2021 (GLOBE NEWSWIRE) – Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative drugs targeting the endocannabinoid system, today announced that it has adjourned its annual meeting 2021 Shareholders’ Meeting (the “Annual Meeting”) to give shareholders additional time …

Read More »

Israeli start-up CytoReason partners with Ferring Pharmaceuticals to find new treatment for IBD

Israeli start-up CytoReason today announced a partnership with Swiss multinational Ferring Pharmaceuticals to implement new treatments for inflammatory bowel disease (IBD). This is the first collaboration between the two companies, combining Ferring’s medical expertise with CytoReason’s artificial intelligence (AI) platform to create cell-centric disease models. CytoReason is developing a computer …

Read More »